A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer.
Authors
Meyer, TCaplin, M E
Palmer, D H
Valle, Juan W
Larvin, M
Waters, J S
Coxon, F
Borbath, I
Peeters, M
Nagano, E
Kato, H
Affiliation
UCL, London, UKIssue Date
2010-02
Metadata
Show full item recordAbstract
To evaluate the combination of the gastrin antagonist Z-360 and gemcitabine for advanced pancreatic cancer.Citation
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. 2010, 46 (3):526-33 Eur J CancerJournal
European Journal of CancerDOI
10.1016/j.ejca.2009.11.004PubMed ID
20006921Type
ArticleLanguage
enISSN
1879-0852ae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2009.11.004
Scopus Count
Collections
Related articles
- A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo.
- Authors: Ueno M, Li CP, Ikeda M, Ishii H, Mizuno N, Yamaguchi T, Ioka T, Oh DY, Ichikawa W, Okusaka T, Matsuyama Y, Arai D, Chen LT, Park YS, Furuse J
- Issue date: 2017 Aug
- Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro.
- Authors: Kawasaki D, Emori Y, Eta R, Iino Y, Hamano H, Yoshinaga K, Tanaka T, Takei M, Watson SA
- Issue date: 2008 Apr
- Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
- Authors: Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C, de Gramont A, GERCOR, GISCAD
- Issue date: 2005 May 20
- A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.
- Authors: Ko AH, Truong TG, Kantoff E, Jones KA, Dito E, Ong A, Tempero MA
- Issue date: 2012 Dec
- Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
- Authors: Philip PA, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo JL, Kim EJ, Dowden S, Zakari A, Borg C, Terrebonne E, Rivera F, Sastre J, Bathini V, López-Trabada D, Asselah J, Saif MW, Shiansong Li J, Ong TJ, Nydam T, Hammel P
- Issue date: 2020 Mar